Applications for the 2025 Cohort are now closed | Join our mailing list to express interest in the 2026 cohort. Thank you!
Join our mailing list to stay up-to-date on our latest news, events, and opportunities!
Welcome to the Emory FluDx Accelerator
The FluDx Accelerator, led by the Emory ADJUST Center and supported by Flu Lab, is designed to accelerate the development and deployment of innovative influenza diagnostic technologies. We partner with diagnostic developers by offering access to well-characterized clinical specimens and independent validation services to help bring high-quality assays to market faster.
Whether you're in the early stages of assay development or preparing for regulatory submission, the FluDx Accelerator can offer tailored support to meet your needs.
Applications for the 2025 cohort are now closed. Join our mailing list to be notified of when the 2026 cohort applications become available. Thank you!
We are currently accepting applications from companies developing influenza diagnostic assays to participate in our inaugural cohort. The initial application will collect basic information about your company, your assay technology, current stage of development, and the types of services or partnership you're interested in receiving from the FluDx Accelerator.
If selected as a part of the 2025 cohort, your company will have exclusive access to services and subsized specimens. Cost structure is dependent on individualized needs, but through the support of Flu Lab, biospecimen access will be made available at a minimum cost to partner companies.
The application deadline closed on August 31, 2025. Please join our mailing list to express interest in the 2026 cohort. Thank you!
All applications will be reviewed in early September, and applicants selected for the next round of review will be invited to a follow-up video conference to further discuss their diagnostic development goals, support needs, and fit with the FluDx Accelerator program.
- Access to Specimens: Including remnant clinical samples, prospective specimen collection, and blinded validation panels (Influenza A and B)
- Independent Validation Studies: Both bench-top and field-based, with options for post-market surveillance.
- Expert Partnership: Connect with experts at Emory and affiliated institutions.
Applications are now closed.
Click below to complete our brief application form. The process should take no more than 10-15 minutes:
For any questions, please contact us at: fludx@emory.edu.